Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Cumberland Pharmaceuticals Inc. (CPIX) had Debt to Equity Ratio of 0.68 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$37.87M |
|
$-6.48M |
|
$6.59M |
|
$31.28M |
|
$44.30M |
|
$-6.43M |
|
$-0.03M |
|
$-6.47M |
|
$-6.47M |
|
$-6.44M |
|
$-6.44M |
|
$-6.44M |
|
$-6.44M |
|
$-6.43M |
|
$-1.53M |
|
14.06M |
|
14.06M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$36.45M |
|
$0.28M |
|
$39.13M |
|
$75.58M |
|
$31.62M |
|
$10.18M |
|
$21.42M |
|
$53.04M |
|
$22.55M |
|
$3.66M |
|
$22.55M |
|
13.95M |
|
| Cash Flow Statement Financials | |
$-0.61M |
|
$0.06M |
|
$0.20M |
|
$18.32M |
|
$17.96M |
|
$-0.36M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.15 |
|
-- |
|
-- |
|
0.31 |
|
|
Debt to Equity Ratio |
0.68 |
82.61% |
|
-16.99% |
|
-16.99% |
|
-4.04% |
|
-17.08% |
|
-17.11% |
|
$-0.68M |
|
-- |
|
-- |
|
-- |
|
0.50 |
|
1.65 |
|
3.24 |
|
112.79 |
|
-28.58% |
|
-176.13% |
|
-8.53% |
|
-19.69% |
|
$1.62 |
|
$-0.05 |
|
$-0.04 |
|